Mitchell Austin Rudy Buys 12,000 Shares of Bonk (NASDAQ:BNKK) Stock

Bonk, Inc. (NASDAQ:BNKK) Director Mitchell Austin Rudy bought 12,000 shares of Bonk stock in a transaction dated Wednesday, June 10th. The stock was acquired at an average cost of $1.37 per share, for a total transaction of $16,440.00. Following the completion of the acquisition, the director directly owned 63,341 shares in the company, valued at $86,777.17. This represents a 23.37% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Mitchell Austin Rudy also recently made the following trade(s):

• On Thursday, April 9th, Mitchell Austin Rudy acquired 31,055 shares of Bonk stock. The stock was bought at an average price of $2.82 per share, with a total value of $87,575.10.

Bonk Price Performance

BNKK stock opened at $1.48 on Thursday. The company has a 50 day moving average price of $2.18 and a 200 day moving average price of $3.15. Bonk, Inc. has a fifty-two week low of $1.25 and a fifty-two week high of $46.90. The stock has a market capitalization of $11.84 million, a PE ratio of -0.32 and a beta of 1.85.

Bonk (NASDAQ:BNKK) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.23) earnings per share for the quarter. The company had revenue of $0.79 million during the quarter. Bonk had a negative return on equity of 148.62% and a negative net margin of 838.37%.

Hedge Funds Weigh In On Bonk

Several institutional investors and hedge funds have recently made changes to their positions in BNKK. Geode Capital Management LLC acquired a new position in shares of Bonk in the 4th quarter valued at $128,000. Jane Street Group LLC acquired a new position in shares of Bonk in the 4th quarter valued at $96,000. Steward Partners Investment Advisory LLC acquired a new position in shares of Bonk in the 4th quarter valued at $37,000. Finally, State Street Corp acquired a new position in shares of Bonk in the 4th quarter valued at $33,000. Institutional investors and hedge funds own 12.55% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on BNKK. Weiss Ratings cut shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, April 29th. Wall Street Zen upgraded shares of Bonk from a “sell” rating to a “hold” rating in a research report on Saturday, June 13th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has a consensus rating of “Sell”.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.